EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C29H24N2O3 |
| Net Charge | 0 |
| Average Mass | 448.522 |
| Monoisotopic Mass | 448.17869 |
| SMILES | CC1(C)CC=C(c2cnc3ccccc3c2)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc21 |
| InChI | InChI=1S/C29H24N2O3/c1-29(2)14-13-23(21-15-19-5-3-4-6-26(19)30-17-21)24-16-20(9-12-25(24)29)27(32)31-22-10-7-18(8-11-22)28(33)34/h3-13,15-17H,14H2,1-2H3,(H,31,32)(H,33,34) |
| InChIKey | WGLMBRZXZDAQHP-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Role: | retinoic acid receptor alpha antagonist A retinoic acid receptor antagonist that antagonises retinoic acid receptor α. |
| Application: | retinoic acid receptor alpha antagonist A retinoic acid receptor antagonist that antagonises retinoic acid receptor α. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| BMS 195614 (CHEBI:132571) has role retinoic acid receptor α antagonist (CHEBI:90713) |
| BMS 195614 (CHEBI:132571) is a benzoic acids (CHEBI:22723) |
| BMS 195614 (CHEBI:132571) is a quinolines (CHEBI:26513) |
| BMS 195614 (CHEBI:132571) is a secondary carboxamide (CHEBI:140325) |
| IUPAC Name |
|---|
| 4-({[5,5-dimethyl-8-(quinolin-3-yl)-5,6-dihydronaphthalen-2-yl]carbonyl}amino)benzoic acid |
| Synonyms | Source |
|---|---|
| BMS614 | SUBMITTER |
| 4-[[[5,6-Dihydro-5,5-dimethyl-8-(3-quinolinyl)-2-naphthalenyl]carbonyl]amino]benzoic acid | SUBMITTER |
| CID:445091 | SUBMITTER |
| 4-[(5,5-dimethyl-8-quinolin-3-yl-6H-naphthalene-2-carbonyl)amino]benzoic acid | ChEBI |
| BMS195614 | SUBMITTER |
| BMS-195614 | ChEBI |
| Registry Numbers | Sources |
|---|---|
| Reaxys:24414151 | Reaxys |
| CAS:253310-42-8 | SUBMITTER |
| Citations |
|---|